Trial intelligence / Profile preview

Antiplatelet therapy after transcatheter aortic valve implantation

2013-003125-28Phase 4Completed

Sponsor
St. Antonius Ziekenhuis
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of clopidogrel in aortic stenosis (AS) (3 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoints: Primary safety outcome (all bleeding) and Co-primary safety outcome (non-procedure related bleeding). Started Nov 2013; status: completed.

02

Drugs

clopidogrel
03

Conditions

aortic stenosis (AS)

Beyond the preview

Go deeper on 2013-003125-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003125-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call